Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This update is a metadata revision with no effect on study data or functionality.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe update shows a minor version change to v3.4.2 replacing the previous v3.4.1, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedA new Revision: v3.4.1 has been added. The previous Revision: v3.4.0 has been removed.SummaryDifference0.0%

- Check53 days agoChange DetectedUI/metadata updates include a glossary toggle (show/hide) and minor wording/version changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3 label.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded a unified 'Locations' section listing participating states (AZ, CA, CO, FL, MN, MO, TN, TX) and removed the prior per-state 'Arizona Locations', 'California Locations', etc., with revision: v3.3.3.SummaryDifference0.8%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.